Article
Molecular biomarkers in acute myeloid leukemia.
Blood reviews - 1 Jan 2017
Prada-Arismendy Jeanette, Arroyave Johanna C, Röthlisberger Sarah
Abstract excerpt
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The pathophysiology of this disease is just beginning to be understood at the cellular and molecular level, and currently cytogenetic markers are the most important for risk stratification and treatment of AML patients. However, with the advent of new technologies, the detection of other molecular markers such as point mutations and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
